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ABSTRACT 
SEASONAL AND ANATOMICAL VARIATION IN COMPACT BONE 
REMODELING IN THE ADULT SHEEP 
Joseph Calcagno 
In order to determine whether ovine compact bone is suitable for study of 
osteoporosis, the remodeling parameters of the untreated animal must be fully 
characterized. Ovine compact bone is an attractive large animal model due to its 
similarities in size and bone remodeling to humans. However hormonal, exercise, 
and dietary changes due to seasonal changes can cause treatment effects to be 
hidden or superimposed on existing changes in the bone. In order to determine if 
any seasonal or anatomical variation occurred in the compact bone remodeling, 
28 skeletally mature Columbia-Rambouillet cross ewes underwent a sham 
ovariectomy, OVX, as part of a larger study.  The animals were divided into 4 
seasonal groups (autumn, winter, spring, and summer) of 7 sheep. Each group 
underwent surgery and was sacrificed 12 months post-op in their respective 
seasons. The radii and ulnae were harvested and processed for analysis. Each 
radius/ulna was divided into 6 anatomical locations (craniolateral, cranial, 
craniomedial, caudolateral, caudal, and caudomedial). Histomorphometric 
analysis of the bone volume to tissue volume ratio, the percent of tissue and 
material remodeling, the mean secondary osteonal radius, and the number of 
cement line interfaces were quantified. Quantitative microdensitometry analysis 
was performed to determine the density of each region with respect to an 
aluminum standard.  2-way repeated measures ANOVAs were performed to 
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determine seasonal and anatomical differences as well as a possible interaction 
between season and anatomical sectors. Significant seasonal and anatomical 
differences as well as seasonality within sectors were observed in the remodeling 
parameters. With the seasonal and anatomical changes in the untreated animal, 
comparison to other models must ensure treatment and follow up times as well 
anatomical locations are similar. This research provides a baseline of seasonal 
and anatomical variations in compact bone remodeling for the untreated adult 
ovine. 
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1.  Introduction 
1.1 Purpose 
Osteoporosis is a major public health threat in the United States. Over 40 million 
people already have the disease or are at high risk due to low bone mass [1]. 
Osteoporosis can occur in both men and women but is more prevalent in older 
women. Certain risk factors such as diet and exercise are shown to reduce the 
chances of developing the disease. Around the age of 30, bone formation begins 
to slow and bone resorption increases. Bone resorption has been shown to 
increase significantly for women after menopause [1]. With a decrease in bone 
mass the risk of fracture increases [2]. In 2002, between $12.2 billion and $17.9 
billion was spent in the United States on hospitals and nursing homes for people 
with osteoporosis-related and associated fractures [1]. In addition to medical 
costs, there is a serious impact on quality of life for patients who fracture their 
bones. Decreased level of function is a critical issue when osteoporotic patients 
incur fractures. Chance of death after an osteoporotic fracture can reach up to 
35% depending on the location of the fracture [3, 4]. 
Due to the high prevalence of osteoporosis, particularly postmenopausal women, 
a large amount of research is directed to the prevention, treatment, or reversal of 
the disease.  The long term goal of this study is to analyze the ovariectomized 
Columbian-Rambouillet sheep as a model for postmenopausal osteoporosis. 
This research will quantify compact bone remodeling the normal adult ovine. This 
introduction will provide the basics behind bone anatomy, physiology, and 
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mechanical properties as they relate to fracture risk. It will discuss the remodeling 
process of bone which is a critical process that affects the rate of bone loss in 
patients. Osteoporosis and particularly postmenopausal osteoporosis will be 
discussed along with potential treatment options. The current state of research in 
the area along with current animal models will be presented. Finally, the compact 
bone of the untreated adult sheep will be presented as a baseline model for 
metabolic disease research. 
1.2 Skeletal Biomechanics 
1.2.1 Composition and Structure of Bone 
Bone provides a framework for motion, protects the body from trauma, acts as a 
reservoir for calcium, and houses marrow which produces blood and stem cells 
[5]. Bone is a dynamic tissue that is continually adjusting to its physiologic and 
mechanical environment [6]. Bone is able to sense changes in the environment 
through changes in the forces exerted on the tissue. These changes in forces 
cause bone to modify its structure in order to accommodate the load and prevent 
damage to the tissue.  
Bone is a nearly acellular material. Its mechanical properties reside primarily with 
the extracellular matrix components discussed later. However, the cellular 
components of bone tissue play an important role in its continual maintenance 
[6]. Bone consists of four specialized cell types in order to maintain the 
homeostasis of the dynamic tissue. Osteoblasts are the cells recruited to 
synthesize or lay down new bone. Osteoblasts are mononuclear cubodial cells 
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differentiated from mesenchymal cells. Osteocytes are former osteoblasts that 
have embedded themselves into the bone matrix. Bone lining cells are also 
former osteoblasts that cover bone surfaces that are not in the process of 
remodeling. Osteoclasts are recruited to remove bone. Osteoclasts are 
multinuclear cells originating from the formation of monocytes originating in bone 
marrow [5]. The role of these cells in the remodeling of bone will be discussed in 
a later section.  
The structure of bone can be broken down into two categories. Trabecular bone 
(also referred to as cancellous or spongy bone) is the porous bone that is found 
in the cubodial bones, flat bones, and the ends of long bones [6]. This bone is a 
loose framework that is filled with marrow. The struts of the matrix are the 
trabeculae.  Cancellous bone on average has a porosity of 75%-95% [6]. 
Compact bone (also referred to as cortical bone) is the dense structure in the 
shafts of long bones and surrounding the trabecular bone. Compact bone on 
average has a porosity of 5%-10% [6]. The compact bone provides structural 
integrity for the skeletal system. Figure 1.1 shows important features of a typical 
long bone. 
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Compact bone can be classified as primary or secondary bone. Primary bone is 
the original bone laid down during growth. Primary bone can be further classified 
as circumferential lamellar bone. Lamellar bone is laid down slow and parallel to 
the bone surface. When a blood vessel is incorporated into the lamellar bone, a 
primary osteon is formed as well as a primary Haversian canal at its center [6]. 
These osteons have a circular appearance when cross sectioned. The other form 
of primary bone is plexiform bone. Plexiform bone occurs during a rapid bone 
growth. In this case lamellar bone mixes with the woven or trabecular bone 
creating a brick like appearance [6]. Secondary bone is a result of the resorption 
and replacement of bone. When new lamellar bone replaces older bone 
secondary osteons are formed. This occurs due to the remodeling process 
discussed later. New bone is formed in the resorption spaces. The secondary 
osteons are approximately 200 µm in diameter and contain a Haversian canal at 
its center [5, 6]. Surrounding the secondary osteon is a boundary known as the 
cement line.  In most adult humans, cortical bone is almost entirely secondary 
bone due to the constant turnover of bone [6].  
1.2.2 Biomechanical Properties of Bone 
Bone is primarily made up of its mineral phase, mainly hydroxyapatite. The 
mineral content is a crystalline structure with a hexagonal symmetry [6]. It also 
contains collagen, non-collagenous proteins and proteoglycans, and water [5]. 
The collagen in bone is primarily type I. The collagen provides loci for the 
deposition of the mineral crystals [6]. The function of the proteoglycans and non-
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collagenous proteins is still unclear, but it is believed they are involved in mineral 
uptake and homeostasis of the bone tissue [6]. 
Cortical bone and trabecular bone have significantly different mechanical 
properties on a millimeter scale. However the trabecular bone is only 20-30% 
less stiff than cortical bone on a micrometer scale [5]. On the nanometer scale, 
bone tissue acts like a reinforced fiber with the hydroxyapatite providing the 
compressive strength and the collagen providing flexibility and strength in 
tension. 
Cortical bone has a longitudinal arrangement with the long axis of the bone. This 
orientation of the lamella provide strong anisotropic properties [5]. The properties 
of cortical bone focus on the strength in the longitudinal direction creating 
strength for compressive loads. Considering most loading conditions of the 
skeletal system, it is critical for the primary arrangement of cortical bone to be 
strongest in compression. Cortical bone is a viscoelastic material making the 
loading rate important for its material properties [5]. Cortical bone is stiffer and 
stronger at high loading rates. During traumatic rapid loading of bone, it is 
important that the bone can accommodate this change while also maintaining 
flexibility at low loading rates. 
Trabecular bone mechanical properties vary depending on densities, structural 
orientation, and the amount of tissue [5]. Density and architecture vary 
depending on location, age, and disease. Due to the mesh architecture of  
trabecular bone it allows for collapse under large compressive strains at a 
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constant stress [5]. This allows for a large amount of energy to be absorbed. For 
the purposes of this study, only cortical bone was observed. However it is 
important to understand the variation in architecture and their effects on the 
mechanical properties. 
Cortical bone, especially human cortical bone, is an osteonal structure. This is 
due to the constant turnover of both primary and secondary bone. With the 
addition of primary and secondary osteons, there is a decrease in the strength of 
the bone [6]. Reilly and Burstein tested Haversian bone and primary cow bone. 
They showed that the osteonal bone showed a 20% decrease in strength in both 
compression and tension [6]. This study and others supported the fact that the 
remodeled osteons were mineral deficient as compared to the primary bone [6]. 
The mineral base of bone provides the foundation for its structural integrity. Hert 
and coworkers showed that fully mineralized osteonal bovine bone and primary 
bone demonstrated similar strength in compression [6]. Carter and colleagues 
indicated that it is not simply a reduction in density that causes decreased 
strength but also increased levels of porosity and possibly orientation of the 
collagen fibers [6]. Burr et al. found that the cement line contained 85%-90% of 
the calcium and phosphorus found in adjacent bone lamella [6]. These results 
present the possibility that the cement line is more compliant and viscoelastic 
than the bone matrix. Osteonal bone shows significant amounts of plastic 
deformation when loaded to failure with greatest deformation when loaded 
parallel to the collagen fibers [6]. Reilly demonstrated that primary bone exhibits 
less plastic deformation than osteonal bone. It can be speculated that this is due 
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these reduce the level or rate of mineralization in the newly formed osteonal 
bone. With decreased mineral content in the bone, the ability to withstand high 
compressive loads without failing decreases. 
Density is a common property when discussing bone material properties. The 
common significance of density is the specific gravity of the solid matrix. 
However the apparent density of bone is mass per unit volume of bulk bone [6]. 
This provides a more significant measurement of density as it relates to bone 
material properties. Since the measurement is volume of bulk bone it would 
include the Haversian canals, marrow spaces, and soft tissue spaces [6]. This 
makes the apparent density dependent on the porosity and the mineral content of 
the bone. 
1.2.3 Quantitative Analysis of Skeletal Biomechanics 
It is important to quantitatively analyze the skeletal system. There are invasive 
and non-invasive ways to analyze bone structure and material properties. Micro 
and quantitative computed tomography can capture a three dimensional 
representation of bone [7]. This methodology can provide a detailed image and 
non destructive analysis of the bone tissue from the millimeter to micrometer 
scale [7]. Bone mass can be measured noninvasively using photon 
absorptiometry developed by Mazess and Cameron [6]. The method uses beams 
of photons scanning across the bone. The intensity of the radiation attenuation 
from the bone is collected and analyzed. This method was improved upon with 
the dual energy x-ray absorptiometry (DEXA) which replaces the radionuclide 
source with low-energy X-rays [6]. Methods using ultrasound have proven 
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loading at the crack location occurs the crack is removed, stress concentrations 
will rise and propagate the crack.  [6]. Two general types of fractures will occur 
from these locations: fast fractures and fatigue fractures [5]. During a fast fracture 
there is a rapid expansion of a crack normally due to trauma or an excessive 
loading condition. Fatigue fractures occur due to repeated cyclic application of a 
sub-maximal loading condition.  
Different researchers are looking at the correlation between bone mechanical 
properties and the prevention of crack development or propagation. The theory of 
linear elastic fracture mechanics is commonly used to describe fractures in 
bones. However others have provided some evidence to suggest that a non-
linear theory can be applied which correlates matrix constituents, micro-crack 
characteristics, and trabecular architecture [10]. 
1.3 Bone Remodeling 
Bone will undergo two processes to add or remove bone. Modeling and 
remodeling involve the same cells and incorporate the formation and removal of 
bone. However, there are significant differences in the function and goals of 
these cells during these two processes. Osteoblasts and osteoclasts are the 
prime movers in the modeling and remodeling. As discussed earlier osteoblasts 
lay down new bone and osteoclasts remove bone.  
Modeling results in a change in the bone size, shape, or both [6]. Modeling 
involves independent actions of the osteoclasts and osteoblasts. Modeling rates 
decrease after skeletal maturity. Remodeling does not normally affect the size 
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reversal, formation, mineralization, and quiescence [6]. Initiation and signaling of 
the remodeling process is not the same as the activation phase of the forming 
resorption space. The activation phase is the process of osteoclasts already 
recruited, to pass through a plane of observation [6]. Initiation and signaling of 
the need for remodeling to occur will be discussed in a later section. During the 
resorption phase the osteoclasts resorb bone at an approximate rate of 40 µm 
per day along the cutting cone shown in Figure 6. The reversal stage is the 
transition of osteoclastic activity to osteoblastic activity [6]. This process can take 
several days. The edge of the reversal area is known as the cement line or 
reversal line. Approximately 30 days are required for humans to pass through the 
combined resorption and reversal periods [6]. During the formation phase 
osteoblasts lay down circumferential lamella at a radial closure rate of about 2 
µm per day [6]. When completed the osteoblasts leave a Haversian canal of 40-
50 µm in diameter in order to ensure proper vascularization of the bone tissue. 
This formation process for adult humans takes an average of 3 months. 
Following the deposition of new bone by the osteoblasts, mineralization of the 
organic matrix occurs. This process occurs after a 10 day lag period known as 
the mineralization lag time [6]. When mineralization occurs, approximately 60% 
of the mineral content is laid down in the first few days and is known as primary 
mineralization [6]. The last 40% of mineralization occurs at a slower rate over a 
period of 6 months to several years during secondary mineralization. The 
difference in mineralization between the high-density removed bone and the 
newly remodeled low-density bone is enough to change the mechanical 
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properties of the new osteon and the surrounding older tissue [6]. After bone 
removal and formation of the secondary osteon occurs the bone enters a period 
of quiescence. The osteoclasts are removed from the area through osteoclast 
apoptosis and the osteoblasts form osteocytes or bone lining cells in the 
Haversian canal [12]. 
1.3.2 Signaling and Initiating Bone Remodeling 
The theory of bone remodeling is controversial and several different theories 
have been published and supported by scientific work.  Wolff’s law refers to 
bone’s ability to sense mechanical loads in which it bears and adjust its 
architecture to sustain these loads [6]. Researchers have developed models to 
simulate bones ability to adjust to environmental loads [13]. These models 
assume that remodeling will remove bone when mechanical stimulus is too low 
and add bone when the stimulus is too high. Other researchers have suggested 
that osteocytes are mechanosensing cells that can produce signals proportional 
to mechanical loading through interstial fluid [14], stretch activated ion channels, 
or electric potentials [15]. A third concept suggested is that osteocytes sense 
fatigue damage and activate remodeling in order to remove the damage [16]. A 
key concept in the remodeling process is that cells in the osteoblast lineage 
control the initiation of remodeling [15].  Work has been performed to show a 
correlation between osteocytes’ apoptosis and remodeling parameters further 
suggesting osteocytes role in the remodeling initiation [17]. All of these concepts 
create controversial theories for the initiation of bone remodeling. Work has been 
done to relate the key concepts and develop a unified theory of bone remodeling 
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Martin [15] proposed a model that incorporates five assumptions or hypotheses 
to unify the theory of remodeling. The first assumption is that bone lining cells are 
the remodeling activators. Second, osteocytes produce and transmit from cell to 
cell a signal proportional to strain or another correlate of mechanical loading. 
Third, osteocytes send an inhibitory signal to osteoblasts that reduces their rate 
of bone formation. Finally, bone lining cells activate remodeling unless inhibited 
by this same osteocytic signal [15]. This model is only relevant to remodeling but 
a connection to modeling must be present due to the same osteocytic cell 
interactions. 
1.3.3 Quantitative Analysis of Bone Remodeling 
Osteonal remodeling is analyzed using histologic sections of bone. This was first 
demonstrated by Frost in the cortex of the human rib [6]. Currently human 
remodeling is analyzed using bone biopsies from the iliac crest. In order to 
perform histomorphometric analysis on bone, remodeling must be simplified to 
well-defined steps.  Histomorphometric analysis of remodeling is important to the 
understanding of problems associated with diagnosing pathologic states and 
defining their etiology [6].  
Frost’s methods of analysis are still used with adaptations to newer technology. 
The sample must be labeled twice, most commonly with tetracycline, in order to 
stain the mineralizing bone and obtain remodeling rates [6]. The time delay 
between stains is commonly 7-14 days with the second label normally a day 
before the specimen is gathered. Cross sections are most commonly taken at 
100 µm thick. The sample must then be stained with tetrachrome, osteochrome, 
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the mean perimeter is calculated [6]. The number of BMUs refilling is counted 
and the number per cross sectional area of bone is calculated. Refilling BMUs 
are identified by the osteoid seam. The mean perimeter and the thickness of the 
osteoid seams are measured. The distance between double labels is measured 
in micrometers. Finally the completed osteons are located and the mean wall 
thickness from the Haversian canal to the cement line is measured [6]. For the 
purposes of this study, no staining was performed. The number of cement lines 
along with the number of secondary osteons can be used in order to determine 
size of secondary osteons and how much bone turnover is occurring. 
1.4 Osteoporosis 
Osteoporosis is characterized by a decrease in bone mass and disruption of the 
micro-architecture of bone [18, 19]. Osteopenia is a less severe form of bone 
loss than osteoporosis. With this decrease in bone mass and a change in 
architecture there is a significant decrease in strength in osteoporotic bone. This 
leads to an increase in fracture risk. Common locations of fracture due to 
osteoporosis are the spine, hip, wrist, humerus, and pelvis [18]. Bone mass loss 
and changes in architecture occur due to a mismatch in the rate that bone is 
removed by osteoclasts and added by osteoblasts. Figure 8 shows a micrograph 
of a 31 year old woman and 70 year old women. The decrease in size and 
change in architecture are readily apparent in the older woman. 
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bone mass early in life plays an important role in determining bone mass later in 
life. 
Women are at a higher risk than men to develop osteoporosis. Men do develop 
osteoporosis. Men tend to have larger skeletons, their bone loss starts later, and 
progresses slower. They also do not have a rapid change in hormones related to 
bone loss [1].It has been shown that the loss of estrogen during menopause 
correlates to the decrease in bone mass [18]. Some of the risk factors that are 
independent of bone mineral density are age, alcohol intake greater than or 
equal to 3 units/day, previous fragility fracture, Rheumatoid arthritis, or a body 
mass index less than or equal to 19 [18]. Risk factors that are dependent on 
bone mineral density are endocrine disease, chronic renal disease, chronic liver 
disease, or malabsorption [18]. These are not all of the risk factors that play a 
role in the development of osteoporosis. 
1.4.1 Postmenopausal Osteoporosis 
Post-menopausal women undergo significant decreases in circulating estrogen 
levels due to minimal production in the ovaries. This systemic decrease in 
estrogen levels can have serious implications in the development of 
osteoporosis. As many as half of all postmenopausal women will develop a 
fracture as a result of osteoporosis [20]. As discussed earlier there are many risk 
factors for the development of osteoporosis. However, systemic estrogen loss in 
postmenopausal women is a major factor in increased bone loss. 
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inhibit osteoclastogenesis. Transforming growth factor-β (TGF-β) stimulates 
osteoclast apoptosis. TGF-β is stimulated by estrogen in the osteoblastic cells. 
Postmenopausal women most likely have increases in IL-1, IL-6, and TNF and 
decreases in the TGF-β. This shift in cytokine levels leads to the prolonged 
lifespan of osteoclasts [21]. Osteoclastogenesis has been shown to be regulated 
by cytokines in the TNF family. The RANK ligand (RANKL) is expressed on the 
surface of osteoblasts. The RANK receptor is located on osteoclast precursors. 
When RANKL and RANK bind the osteoclast precursors differentiate to 
osteoclasts. Osteoprotegerin is a decoy receptor that binds to RANKL to inhibit 
osteoclast differentiations [22]. This interaction reinforces the link between the 
presences osteoblasts and osteoclast function. 
1.4.2 Osteoporosis Treatment Options 
There are two main methods for the treatment of osteoporosis. Due to the 
significant decreases in estrogen levels post-menopause, estrogen replacement 
treatments have been researched to compensate for the increased levels of bone 
loss. Bisphosphonates are also a treatment option for patients with osteoporosis. 
In order to determine treatment options and dosage requirements physicians use 
primarily two methods. Most clinicians used bone mineral density (BMD) as a 
means to determine fracture risk in a patient [23]. Dual energy x-ray 
absorptiometry is used to measure the BMD of a patient. A low BMD is one of the 
risk factors for fractures. Recently, there is a recommendation to determine 
treatment options based on estimates of a 10-year fracture risk. This analysis 
uses information on multiple risk factors such as smoking, corticosteroid uses as 
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well as BMD. Using the 10-year method of analysis was shown to better match 
physician-prescribed medications to the clinical guideline recommendations [23]. 
Changes in dosing methods have been analyzed in order to improve adherence 
to treatment protocol. The difficulty with some of the treatment protocols is the 
demand of weekly medication. Changing dosing of bisphosphonates from a once 
weekly dose to a once monthly dose showed longer patient usage. However 
effects of fracture risk were not determined and need to be analyzed before wide 
spread changes in treatment protocols [24].  
As discussed earlier, estrogen inhibits the production of cytokines such as IL-1, 
IL-6 and TNF that stimulate osteoclastogenesis. It also stimulates cytokines such 
as TGF-β that increase osteoclast apoptosis.  Treatment initiation can have an 
effect of the effectiveness of the estrogen. Four different comparisons were made 
between users who were continuous users, partial users, past users and those 
who have never used estrogen[20]. Those with continuous estrogen use and 
partial use showed significant decreases in mean bone density losses (Figure 
10). Probability of fractures also decreased in continuous and partial users as 
shown in Figure 11. 
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Treating osteoporosis with estrogen does have potential downsides. Estrogen 
does have a protective effect against osteoporosis and fractures when compared 
to those who never used estrogen in the past. However, as shown in Figure 11, 
fracture risk does continue to increase with age[20]. Other side effects 
corresponding to estrogen use include possible mastalgia, headaches, and 
dyspepsia [25].  
Bisphosphonates have been shown to provide significant suppression of bone 
resorption. They have been shown to have long term effects after termination of 
treatment due to their potential sequestering by hydroxyapatite crystals. The 
release of the stored bisphosphonates occurs during the remodeling process 
inhibiting osteoclast function [25]. Bisphosphonates have been shown to inhibit 
the melavonic acid pathway which is critical for osteoclast function [26]. One 
downside of inhibiting osteoclast function stems from the coupling action of 
osteoblasts and osteoclasts in the remodeling process. With inhibition of 
osteoclast function there is lower levels of bone loss. However, this also means 
that there are decreased levels of new bone turnover. This causes potential 
detrimental effects on the quality and strength of the bone. Bisphosphonate 
treatment has also been shown to cause upper gastrointestinal side effects [25].  
Studies have been performed in order to characterize the effects of combining 
estrogen with a bisphosphonate treatment. With each treatment operating 
through different mechanism to minimize bone resorption the theoretical benefits 
are positive. The bisphosphonate alendronate was combined with conjugated 
equine estrogen and its effects on bone mineral density were compared to a 
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1.5 Animal Models 
In order to develop treatment protocols to be used in humans, they must be 
deemed safe and effective. This is done through extensive laboratory testing and 
animal trials. The progression of animal testing starts with an inexpensive small 
animal model and advances to a diseased large animal model. The goal is to 
minimize cost and time by troubleshooting treatments in the smaller animals, 
allowing only promising treatments to be studied on the larger models.  Large 
animal models must have similar characteristics to human osteoporosis and 
allow for testing of drugs as well as devices used to fix fractures, replace joints, 
and other orthopedic devices. These devices must be able to perform in low 
bone density environments and not compromise the structural integrity of the 
native tissue [27]. 
Rodents are a common animal model due to their short life span, allowing for 
easier studies on aging.  Rodents do show cortical thinning and increased 
fragility due to ovariectomy, but the effects on fracture risk are unclear. Research 
has been performed on the mandible of the mouse. The mouse does not 
undergo significant amounts of remodeling. By ovariectomizing the mouse, 
remodeling was stimulated. Suppression of this remodeling with 
bisphosphonates was observed [28]. Rats are a common animal used in studies 
due to their relative lower cost. Ovariectomized rats have been used to study the 
effects of bisphosphonates on estrogen deficiency [29]. Rats’ lack of Haversian 
remodeling reduces the strength of correlation to humans [30].    
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Rabbits have been used as a model of osteoporosis. Rabbits are a good small 
animal model for bone biomechanics due to the fact that they undergo Haversian 
canal remodeling and skeletally mature rapidly [31]. They are commonly used to 
study bone ingrowth to implants and implant surfaces[30].  While these models 
are useful due to their lower cost and easier housing conditions, they do not 
provide sufficient means to study implant dynamics on a human scale.  
Dogs have been used for bone studies due to their larger size and Haversian 
system of remodeling.  However, there are limitations to the study of 
postmenopausal osteoporosis. Studies have shown that dogs without ovaries 
and uterus and with sedentary lifestyles show limited to no fracture risk as 
compared to postmenopausal women [30].  Nonhuman primates seem like a 
viable candidate for postmenopausal osteoporosis and osteopenia research. As 
discussed earlier hormones play a large role in the onset of osteoporosis. 
Primates have a similar endocrine system to humans. In order for primates to be 
studied under postmenopausal conditions they must be aged to approximately 9 
years [30]. This results in extensive cost for housing and animal management.  
1.5.1 Proposed model 
The sheep, in particular the ewe, is a promising large animal model for 
osteoporosis research. Its size allows for full scale device implantation and 
analysis. Sheep have been shown to have similar metabolic rate (O2 
consumption per gram of body weight), 0.22, to humans, 0.21. Rats and dogs 
have metabolic rates of 0.87 and 0.33 respectively [32, 33].  Young sheep, 3 to 4 
years, have primary bone consisting of woven and lamellar bone. As the sheep 
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osteoporosis. Ewes, unlike human females, have annual anestrus periods lasting 
approximately 1-2 months [32]. The gastrointestinal system of sheep is different 
than humans. The rumen microflora can alter the administered drugs. This 
presents complications when studying the effects of oral absorption of drugs [34, 
35].  
Two important characteristics of the sheep as a model for osteoporosis and more 
specifically postmenopausal osteoporosis are the season of analysis and their 
age.  The remodeling cycle in sheep has been shown to complete in 
approximately three months. Remodeling rates were seen to increase by three 
months in ovariectomized ewes. Changes in bone loss of the ovariectomized 
ewes compared to the control were seen by 6 months [36, 37]. In other studies 
significant decreases in mechanical and histomorphometric data were not seen 
in the spine and ilium until 12 months [32, 38]. Using micro-CT, significant 
changes can be seen in the trabecular micro architecture as seen in Figure 14. 
The left image is the control. The middle is taken to 6 months and the left image 
was a ewe sacrificed at 12 months [38]. 
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volume ratio was significantly higher during autumn when compared to winter 
[33].  
The ovariectomized sheep provides a large scale animal model for 
postmenopausal osteoporosis. It allows for functional testing of both drugs and 
devices in an osteoporotic setting. Further characterization of the seasonal 
effects on the remodeling patterns of the ewe is needed in order to fully grasp the 
effects of treatment protocols. With this research a quantifiable model of 
seasonal and anatomical variations in cortical bone remodeling will be 
determined as a baseline for comparison to ovariectomized sheep. 
1.6 Study Objectives 
The purpose of this study is to quantify compact bone remodeling in adult ovine 
bone as a function of sampling season.  The remodeling parameters that will be 
measured are the ratio of bone volume to tissue volume, the percent of tissue 
remodeled, the percent of material remodeled, mean secondary osteonal radii, 
cement line interfaces with tissue, and cement line interfaces with material.  The 
measurement will be taken from the compact bone of the radius and ulna of the 
left leg. Variations across seasons, anatomical location, and a possible 
interaction or seasonality within anatomical regions will be analyzed. 
Previous studies have shown that sheep undergo seasonal changes in bone 
properties [27, 33, 34]. Little research has been done to compare changes in 
remodeling characteristics at different anatomical locations or an interaction 
between season and anatomical sectors. Seasonal and anatomical remodeling 
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changes are expected in the compact bone. This model will determine where 
changes are occurring in across each anatomical sector and each season. With 
this information future studies will be able to ensure that comparisons made 
between models are showing relevant information and not changes due to these 
seasonal and anatomical parameters. 
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2. Methods 
2.1 Animal Preparation 
As part of a larger experiment  under Animal and Care Use Committee approval 
112 skeletally mature, age greater than 5 years, Columbia-Rambouillet cross 
ewes were obtained and kept at Colorado State University, Ft. Collins, Colorado. 
The animals were kept in dry lots and fed a grass-alfalfa hay mixture at 41° 
latitude and 1500 m altitude for the duration of the experiment. These 112 ewes 
were split into four seasonal groups of 28; autumn, winter, spring, and summer. 
These seasonal groups were then divided into groups of 14. Both groups were 
anesthetized and underwent surgery at the large animal surgery facilities at the 
College of Veterinary Medicine and Biomedical Sciences at Colorado State 
University. One group of 14 underwent an ovariectomy (OVX) in which the 
ovaries were identified and removed. The other 14 underwent a sham surgery in 
which the ovaries were identified, handled, and not removed. The groups of 14 
were further divided into two groups. Seven of the ewes were sacrificed 3 months 
postoperatively and 7 were sacrificed 12 month postoperatively. The seasonal 
group represents the month that surgery was performed. Summer sheep 
underwent surgery in August. Autumn, winter, and spring, underwent surgery in 
November, February, and May respectively. One of the 12 month autumn sham 
sheep died prematurely and was included in the 3 month data as part of another 
experiment. 
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2.2 Specimen Preparation 
Post sacrifice, the right and left radius and ulna of the sheep were removed and 
stored wrapped in saline-soaked paper towel and stored in sealed plastic bags at 
a temperature of -20 °C. These samples were sent to Henry Ford Medical 
Hospital where they were prepared for analysis. The center 50mm of the 
diaphysis was removed with a band saw (Model 5212, Hobart Corporation, Troy, 
OH).  The radius was then divided into six anatomical sectors using the Exakt 
cutting-grinding system (Exakt Corporation, Oklahoma City, OK). The sectors 
were organized into cranial, caudal, craniolateral, craniomedial, caudomedial, 
and caudolateral regions (Figure 15).  
 
Figure 15 Approximate anatomical radial-ulnar sectors divided by the grey lines. The cranial sector 
is at the top right and lateral is the top left side of the image. 
In each anatomical sector, 1.75x1.75x19mm longitudinal cortical beams were 
obtained. Dynamic mechanical testing was performed on the cortical beams of 
the left radii and ulnae for analysis in another study. From the center of left radii 
and ulnae beams a 150 µm section was cut out. The remaining distal end of the 
beam was used for drying and ashing as means to determine density. The 
proximal section was frozen for analysis at a later time. The 150 µm sections 
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were then ground down by hand using fine grit sand paper to a finish thickness of 
100 µm. Microradiographs using 2506AGHD 2.5x2.5x0.060 High Definition Photo 
Emulsion Plates and a HB Cabinet Faxitron (HTA Enterprises, Microtome 
Technology Products, San Jose, CA) were taken of each section at 25 kV for 20 
minutes at 3 mA (Figure 16). Sections from two sheep were placed on each 
microradiograph with an aluminum step wedge made with Reynolds Aluminum 
Foil in the middle. The aluminum step wedge was created by taping multiple 
layers of aluminum together in stair step pattern creating different levels of 
thickness. Taking micro-radiographs of both the aluminum and the specimens 
under the same conditions allows for comparison between the two. The thickness 
of aluminum is known for each step. By comparing image intensities of the 
specimens to the aluminum step wedge a measurement of density with respect 
to aluminum can be made. With this methodology variations in day to day 
differences in microscope parameters and plate development can be controlled. 
This also provides a non destructive density measurement unlike ashing in which 
the specimen is destroyed. This methodology is a modification of Boivin and 
Meunier [42]. 
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cement line interfaces. The material cement line interfaces is the raw cement line 
interface count divided by the BV/TV. The mean secondary osteon radius was 
calculated by multiplying the percent of tissue remodeled by a constant of 
632025 as determined by Wessel [43], divided by the square root of π, times the 
number of secondary osteons. The ratio of cement line interface to mean 
secondary osteonal radius was also analyzed during the statistical analysis. This 
is to determine whether the size of the secondary osteons is changing with 
respect to season and anatomical location. 
2.3.2 Densitometry 
In order to determine the density of the bone, a reference material of known 
density must be used to quantify the level. Aluminum was used for the purposes 
of this study. Aluminum is commonly used for cortical bone due to its similar x-
ray attenuation. Aluminum is also uniform on a micron scale and accurate 
measurements of the thickness of aluminum foil are possible [44]. The density 
measurements of the samples are reported in the equivalent thickness of 
aluminum (ETA). In order to calculate the density, images were captured using 
the Olympus BX-41microscope with the attached Retiga EXi Q Image camera 
and a 4x objective. Pictures of each sample and each level of the aluminum step 
wedge were taken. In order obtain accurate results the light intensity and all other 
image settings on the microscope were kept at the same levels when imaging 
each sample and step wedge on a particular microradiograph. Each sample was 
compared to the aluminum step wedge on its respective microradiograph. The 
settings were reset and recalibrated for each microradiograph. 
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change with the season differently at different anatomical locations. On the other 
side, the anatomical distributions of the parameter may change with the seasons. 
For this reason an interaction between season and sector was included in the 
analysis.  Post-hoc Fisher LSD tests were performed to determine where the 
differences occurred in the analysis. An alpha of 0.05 was used for both tests. 
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3. Results 
3.1 Histomorphometry 
Measurements were made for autumn, winter, and spring. Summer 
histomorphometric measurements were already performed as part of the larger 
experiment [43]. The average value of the four quadrants in each individual 
sector for BV/TV, percent remodeled tissue, percent remodeled material, mean 
secondary osteonal radii, cement line interfaces (tissue), and cement line 
interfaces (material) are reported in Appendix A. Tables I, II, III, IV, V, and VI 
summarize the average remodeling factors and their standard error for each 
season and the anatomical sectors.  
   48 
 
Table I BV/TV for adult 12 month control compact bone 
BV/TV 
Seasons 
Group Mean Standard Error 
Autumn 0.972 0.00472 
Winter 0.951 0.00454 
Spring 0.958 0.00437 
Summer 0.961 0.00437 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 0.964 0.00430 
Cranial 0.962 0.00430 
Craniolateral 0.963 0.00430 
Caudomedial 0.958 0.00454 
Caudal 0.952 0.00430 
Caudolateral 0.965 0.00430 
 
Table II Percent remodeled tissue for adult 12 month control compact bone 
Percent Remodeled Tissue (Remodeled Tissue/Total Area) 
Seasons 
Group Mean Standard Error 
Autumn 0.330 0.0305 
Winter 0.257 0.0294 
Spring 0.288 0.0283 
Summer 0.339 0.0283 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 0.206 0.0258 
Cranial 0.348 0.0258 
Craniolateral 0.213 0.0258 
Caudomedial 0.312 0.0272 
Caudal 0.408 0.0258 
Caudolateral 0.334 0.0258 
 
 
   49 
 
Table III Percent remodeled material for adult 12 month control compact bone 
Percent Remodeled Material (Remodeled Tissue/Bone Area) 
Seasons 
Group Mean Standard Error 
Autumn 0.339 0.0314 
Winter 0.270 0.0302 
Spring 0.301 0.0291 
Summer 0.351 0.0291 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 0.214 0.0266 
Cranial 0.360 0.0266 
Craniolateral 0.220 0.0266 
Caudomedial 0.325 0.0281 
Caudal 0.427 0.0266 
Caudolateral 0.345 0.0266 
 
Table IV Mean secondary osteonal radius (µm) for adult 12 month control compact bone 
Mean Secondary Osteonal Radius (µm) 
Seasons 
Group Mean Standard Error 
Autumn 55.133 2.383 
Winter 52.667 2.292 
Spring 54.582 2.206 
Summer 62.093 2.206 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 55.469 2.522 
Cranial 55.668 2.522 
Craniolateral 54.056 2.522 
Caudomedial 58.056 2.663 
Caudal 56.527 2.522 
Caudolateral 56.701 2.522 
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Table V Cement line interfaces (tissue) for adult 12 month control compact bone 
Cement Line Interfaces (Tissue) (mm/mm2) 
Seasons 
Group Mean Standard Error 
Autumn 37.298 3.120 
Winter 28.456 3.002 
Spring 28.869 2.889 
Summer 33.512 2.889 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 21.140 2.315 
Cranial 39.625 2.315 
Craniolateral 23.400 2.315 
Caudomedial 31.587 2.445 
Caudal 43.080 2.315 
Caudolateral 33.519 2.615 
 
Table VI Cement line interfaces (material) for adult 12 month control compact bone 
Cement Line Interfaces (Material) (mm/mm2) 
Seasons 
Group Mean Standard Error 
Autumn 38.471 3.230 
Winter 29.932 3.108 
Spring 30.213 2.990 
Summer 34.861 2.990 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 21.914 2.392 
Cranial 41.071 2.392 
Craniolateral 24.272 2.392 
Caudomedial 32.972 2.526 
Caudal 45.237 2.392 
Caudolateral 34.750 2.392 
 
The means and standard errors were obtained from the 2-way repeated 
measures ANOVA. Seasonal and anatomical differences as well as possible 
seasonality within the anatomical regions were determined with a p value less 
than 0.05. Table VII is the 2-way repeated measures ANOVA p values for each 
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variable. The ratio of cement line interface to osteonal radius was calculated 
within the statistical software. This ratio determines whether there are changes in 
the size of the osteons with the seasons or within the sectors. 
Table VII P values for 2-way random measure ANOVA of remodeling variables 
2-way Repeated Measure ANOVA: p values 
Parameter Season Sector Interaction 
BV/TV 0.035 0.322 0.930 
% Remodeled (Tissue) 0.193 0.000 0.230 
% Remodeled (Material) 0.232 0.000 0.193 
Cement Line Interface (Tissue) 0.150 0.000 0.008 
Cement Line Interface (Material) 0.196 0.000 0.005 
Mean Secondary Osteon Radius 0.034 0.911 0.424 
CLI: Osteonal Radius Ratio 0.107 0.000 0.000 
 
Summer Autumn Winter Spring
B
V
/T
V
0.90
0.92
0.94
0.96
0.98
1.00 (a)
(b)
(b)
(a,b)
 
Figure 24 Mean BV/TV values and standard deviations for each season 
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A subtle but significant difference was seen in the BV/TV between seasons 
(Figure 24). Winter and spring had significantly lower BV/TV values or higher 
levels of porosity than autumn. Summer was shown not to be significantly 
different than any other season.  Significant anatomical differences or seasonality 
within the regions was not seen in the BV/TV. There was clear and significant 
anatomical variation in the percent of tissue and material remodeled as shown in 
Figure 25 and 26 respectively. The higher levels of remodeling were seen in the 
caudal and cranial sides of the bone. These regions correspond to the high 
tensile (cranial) and compressive (caudal) regions [45]. The lower value 
measurements were seen to be closer to the neutral axis of the bone. Seasonal 
variation and seasonality within anatomical regions was not observed in the level 
of remodeling in the radius/ulna. 
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Figure 25 Anatomic variability in the percentage of tissue remodeled. The values for each sector are 
oriented in their approximate anatomical location on the polar graph. Distance radially away from 
center determines the value with respect to the scale. 
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Figure 26 Anatomical variability in the percentage of bone material remodeled. The values for each 
sector are oriented in their approximate anatomical location on the polar graph. Distance radially 
away from center determines the value with respect to the scale. 
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Figure 27 Seasonal variability in the mean secondary osteonal radius with standard deviations 
A slight but significant seasonal difference was seen in the mean secondary 
osteonal radius (Figure 27). Animals sacrificed in the summer were shown to 
have larger secondary osteons when compared to the other seasons. No 
significant anatomical differences or seasonality within the anatomical regions 
was seen in the mean secondary osteonal radii. The mean values of the 
secondary osteonal radii are smaller than the 100 micrometer reference radii of 
human secondary osteons.  Cement line interfaces for tissue and bone material 
showed a significant seasonality within the anatomical regions as seen in Figures 
28 and 29 respectively. The caudolateral and caudomedial regions showed more 
seasonality than the other sectors. The other sectors showed more variability 
between sectors and seasons. The ratio of cement line interfaces to the mean 
secondary osteons showed a similar seasonal and anatomical distribution as the 
cement line interface distributions. 
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Figure 28 Anatomic variability within seasons for the number of tissue cement line interfaces. The 
values for each sector are oriented in their approximate anatomical location on the polar graph. 
Distance radially away from center determines the value with respect to the scale. 
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Figure 29 Anatomic variability within seasons for the number of bone cement line interfaces. The 
values for each sector are oriented in their approximate anatomical location on the polar graph. 
Distance radially away from center determines the value with respect to the scale. 
Su 
Su 
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3.2 Densitometry 
The mean pixel intensities and equivalent thicknesses of aluminum for each 
specimen and the calculation used from the step wedge keys are tabulated and 
reported in Appendix B and Appendix C. The mean pixel intensities of each level 
of aluminum in the step edges were measures and graphed versus their 
equivalent thicknesses. A best fit power function was determined for each graph. 
The mean pixel intensities of the samples were inputted to their corresponding 
best fit lines to determine their equivalent thickness of aluminum, ETA. The mean 
ETA values and the standard error for each season and anatomical sectors are 
shown in Table VIII.  
Table VIII Densitometry values (ETA) 
Densitometry (ETA) (mm) 
Seasons 
Group Mean Standard Error 
Autumn 0.100 0.00484 
Winter 0.0989 0.00448 
Spring 0.105 0.00448 
Summer 0.0844 0.00448 
Anatomical Sectors 
Group Mean Standard Error 
Craniomedial 0.0965 0.00237 
Cranial 0.101 0.00237 
Craniolateral 0.104 0.00237 
Caudomedial 0.0980 0.00237 
Caudal 0.0922 0.00237 
Caudolateral 0.0915 0.00237 
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Figure 30 Seasonal variability in density measured in equivalent thickness of aluminum, ETA with 
standard deviations. 
Upon statistical analysis a significant seasonal difference (p=0.022) was seen in 
the density of the bone (Figure 30). Animals sacrificed in the autumn, winter, and 
spring had significantly denser bone than those sacrificed in the summer. No 
significant difference was seen between autumn, winter, and spring.  A significant 
anatomical difference (p=0.002) was also seen in the densities (Figure 31).  The 
densest region in the radius/ulna was the craniolateral sector. Higher levels of 
density were observed in the cranial, craniolateral, and caudomedial sectors.  No 
significant seasonality within the anatomical regions was seen.  
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Figure 31 Anatomical variability in density measured in equivalent thickness of aluminum, ETA. The 
values for each sector are oriented in their approximate anatomical location on the polar graph. 
Distance radially away from center determines the value with respect to the scale. 
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4. Discussion 
Osteoporosis incidence is increasing rapidly with the ever growing elderly 
population [46]. Osteoporosis results from a decrease in bone mass. With 
decreasing bone mass the risk of fracture increases. Osteoporosis related 
fractures can cause a detriment financially as well as decrease the quality and 
quantity of life for the patient. Fracture fixation and healing can be difficult in 
osteoporotic bone. Fracture risk assessment is commonly performed using dual 
X-ray absorptiometry in order to determine bone mineral density.  Most patients 
are not diagnosed with osteoporosis until after incurring a fracture from a minor 
traumatic event [19]. It is important to understand the risk factor associated with 
developing osteoporosis in order to diagnose and treat before fractures occur. 
There are many risk factors that can increase the risk of fracture in older patients. 
Exercise, smoking, alcohol intake, and age all increase the risk of osteoporosis 
related fractures. However, a history of fractures before the age of 50 can 
increase the risk of fracture in elderly women [47].  
Developing methods to diagnose and quantify fracture risk in these patients 
before fractures occur is critical. High resolution peripheral quantitative computed 
tomography as well a micro-magnetic resonance imaging can provide in vivo 
assessment of the bone architecture and let doctors visualize the potential for 
fracture risk (Figure 32) [48]. Bone density is not the only factor contributing to 
the strength. Trabecular and cortical architecture, mineralization, and micro-
fractures also contribute to the strength of the bone. Magnetic resonance and 
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By removing the ovaries (ovariectomizing) of animals or humans osteopenia and 
osteoporosis can be induced. A rapid increase in bone turnover resulting in 
increased bone loss has been shown in multiple animal models [50]. Cancellous 
bone loss was seen in the proximal tibial metaphysic of ovariectomized rats and 
occurred during the first several months post-ovariectomy. Similar transient rapid 
phase bone loss has been seen in human women in early stages of estrogen 
deficiency [50]. Similar changes in bone loss were observed in ovariectomized 
monkeys. Using dual-energy X-ray absorptiometry of the vertebrae showed 
consistent differences between the control and ovariectomized animals [51]. This 
interaction in monkeys is critical due to their similarities to human cortical bone 
remodeling [51]. 
Significant changes were seen in the biomechanical properties of the 
ovariectomized ovine when compared to a control. Thirty eight skeletally mature 
sheep were divided in to an ovariectomized and a control group. Unconfined 
compression testing was performed on cross sections of the mid-diaphysis of the 
left metatarsal. The ovariectomized samples showed significantly lower yield 
strengths and lower mechanical properties than the control sheep (Figure 33) [2]. 
If devices such as pins and plates are needed for proper healing of the fracture, 
integration in the weaker bone can cause complications. These devices can not 
compromise the integrity of the native bone [27]. In order to test drugs or devices 
to treat osteoporosis an appropriate animal model must be developed.   
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provides a large animal model with large scale bone remodeling due to 
hormonal, exercise, or dietary changes. Sheep undergo similar Haversian 
remodeling to humans in response to these conditions. Most sheep are seasonal 
breeders and undergo a natural anestrus period resulting in an estrogen depleted 
state. This condition creates a postmenopausal state during these seasons. 
From a research perspective this seasonal state can be a benefit. Having the 
sheep enter anestrus allows for analysis of the effects of menopause without 
ovariectomizing the sheep assuming the study is finished before spring and the 
exit of anestrus. However, this is a key component of the model that must be 
taken into consideration when considering comparisons of treatment and follow-
up times. The seasonality of sheep has been shown to be regulated by 
hormones such as melatonin [40, 41]. Changes in the loading patterns of the 
radius and ulna due to inactivity in different seasons have potential effects on the 
rate of bone turnover in varying seasons [34].  
The data presented in this study shows significant effects of season on the levels 
of porosity (BV/TV) and the size of the mean secondary osteonal radius. The 
porosity levels in the bone show a cyclic nature across the seasons. An increase 
in porosity is seen in winter possibly due to the entering of winter anestrus and 
changes in the levels of bone turnover. During winter a decrease in activity would 
result in decrease in loading. With decreases in loading there is the potential for 
a decrease in the stimulus for remodeling. A recovery is seen through spring and 
summer until the BV/TV levels reach a maximum in autumn. The secondary 
osteon size significantly increases in summer. This potentially could be in 
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response to the increased porosity in winter. Larger secondary osteons means 
that there is an increased area of new bone turnover. With increased osteonal 
size, there is a larger amount of secondary bone. Secondary bone tends to be 
less dense due to the lower levels of mineralization when compared to primary 
bone or even with older secondary bone. With a lower mineralization in bone a 
decrease in density will be seen. This observation is supported by summer 
showing significantly lower density levels with respect to the other seasons. 
Significant anatomical variations in the densities of the samples were also seen.  
When looking at where the increased levels of remodeling (% tissue and material 
remodeled) are occurring, the data shows significant anatomical variation in the 
sections. Higher levels of remodeling are occurring in areas of high compressive 
or tensile stress regions. These areas tend to be regions in which remodeling has 
already occurred with the craniolateral and craniomedial regions showing the 
highest levels of primary bone. Seasonality was observed in the number of 
cement line interfaces as well as the ratio of cement line interfaces to mean 
secondary osteonal radius. Seasonal variation was seen in all sectors except the 
caudolateral and caudomedial sectors. From this data it can be speculated that 
remodeling tends to occur in regions that have previously remodeled. 
This research has shown seasonal and anatomical variations in various aspects 
of compact bone remodeling in the adult Columbian-Rambouillet cross ewes. 
These variations were not due to a treatment or implantation of a device, but 
provide a baseline of remodeling factors. Since significant changes were 
observed, future research needs to take these factors into consideration when 
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choosing a treatment model. Treatment times and follow up times must be kept 
consistent between the treatment groups in order to provide a valid comparison. 
In addition, samples should be obtained from similar anatomic regions. These 
sheep were all housed in dry lot conditions in a USDA 5/6 climate zone. 
Comparison of sheep housed in different climate and housing conditions should 
not be made. These factors should be kept as consistent as possible.    
One of the limitations of the study is a purchase cohort effect cannot be excluded 
from consideration. The sheep were already skeletally mature upon arrival at the 
facility in Colorado. The cohort effect was minimized with a post operation time 
span of 12 months or 3 to 4 remodeling cycles allowing any previous tissue 
responses to be remodeled away. The sheep were also housed at the same 
facility, with the same feed quality, sunlight, breeding, and exercise conditions.  
Another limitation to the study is that the microradiographs are two dimensional 
integrations or projections of a three dimensional structure. The thickness of the 
section is a significant proportion of the dimensions of many of the features being 
measured. This presents difficulties and room for noise in the histomorphometric 
analysis and whether structures are present in the viewing plane and whether 
they should be counted. 
Micro radiograph exposure presented limitations in the ability to make 
histomorphometric measurements. A few sectors had to be removed from 
analysis due to the inability to visualize the structures in the sample. Exposure 
issues also presented limitations during density measurements.  Denser samples 
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were washed out under the higher light intensities needed to visualize the less 
dense sectors. This can be accommodated by capturing a new step wedge key 
for each section at the appropriate light intensity.  
There is a large potential for future work in this study. During densitometry 
analysis, porosity was not corrected for when calculating equivalent thickness of 
aluminum measurements. Samples that had larger levels of porosity could be 
represented as low density bone. Thresholding images to remove for porosity 
could result in a more accurate measurement of density. This measurement 
would represent the density of bone material and not tissue density. This 
measurement would be more equivalent to densities determined by ashing. 
The larger study consisted of sheep at different time points and treatment 
protocols. With these samples similar measures of remodeling in adult ovine 
bone will be made under the same protocol. Animals in the same purchase 
cohorts were sacrificed after 1 remodeling cycle or 3 months after arrival at the 
facility. Adult sheep were also ovariectomized and then sacrificed at 12 and 3 
months. These sheep immediately undergo a state of estrogen depletion and 
provide a potential model for postmenopausal osteoporosis.  
Studying seasonality in human bone remodeling is difficult due to inconsistent 
social and environmental factors. However, research has shown cyclic patterns 
and seasonal variability in the biochemical markers of remodeling in humans, 
particularly adult females (Figure 34) [52, 53].   Other biological factors such as 
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5. Conclusions 
The adult ewe provides a robust economical animal model for the study of 
compact bone remodeling. Sheep have large scale Haversian remodeling due to 
hormonal, exercise, or dietary changes similar to humans. Their bone size allows 
for implantation studies of orthopedic implants for the treatment or prevention of 
osteoporosis related fractures. However, due to the seasonal breeding of most 
species, treatment effects can be masked by changes in remodeling factors 
during anestrus. During anestrus, the ewes undergo an estrogen depleted state 
altering hormone levels critical for regulating remodeling. Remodeling 
parameters in a control animal must be quantified before disease and treatment 
models can be analyzed. 
This research has shown significant seasonal and anatomical variations in 
compact bone remodeling. Seasonal variation was seen in porosity, mean 
secondary osteonal radius, and density across the samples. Significant 
anatomical variations were seen in both percent remodeling measurements as 
well as density. Seasonality within the anatomical regions was seen in the 
cement line interfaces as well as the ratio of cement line interface to secondary 
osteonal radius.  
With significant variations between seasons and anatomical sectors it will be 
critical that future studies take time of treatment, length of follow up, and sample 
location into consideration when making comparisons to treatment data. 
Comparing data in different seasons or anatomical locations might present a 
false positive in the results due to changes in remodeling characteristics across 
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these variables. In order to ensure that data is not masked or amplified by the 
background remodeling, location and time points should be equivalent between 
models. However, if time and anatomical variations between models are not 
possible, smaller deviations in remodeling parameters were seen in the medial 
and lateral sectors as well as in winter and spring. With these remodeling 
characteristics quantified for compact bone of the adult sheep comparisons can 
be made to the ovariectomized ewes’ to quantify the models relevance to 
postmenopausal humans.  
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Appendix A 12 Month Control Histomorphometry Data 
12 Month Summer Control 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 0.986 0.944 0.931 0.972 0.931 0.972 
C03 0.963 0.951 0.951 0.972 0.944 0.944 
C06 0.972 0.944 0.972 0.958 0.931 0.993 
C07 0.986 0.944 0.903 0.965 0.958 0.979 
C11 0.931 0.958 0.951 0.958 0.979 0.972 
C22 0.972 0.979 0.991 0.972 0.979 0.938 
C26 0.958 0.993 0.972 0.935 0.972 0.986 
Average Percent Remodeled (Tissue) (Remodeled Tissue/Total Area) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 0.563 0.463 0.458 0.491 0.333 0.417 
C03 0.444 0.500 0.208 0.090 0.389 0.438 
C06 0.319 0.153 0.333 0.153 0.313 0.326 
C07 0.340 0.250 0.083 0.521 0.451 0.507 
C11 0.083 0.139 0.118 0.160 0.479 0.222 
C22 0.111 0.444 0.324 0.375 0.243 0.500 
C26 0.347 0.472 0.410 0.380 0.368 0.514 
Average Percent Remodeled (Material) (Remodeled Tissue/Bone Area) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 0.570 0.490 0.492 0.504 0.354 0.429 
C03 0.462 0.525 0.220 0.092 0.409 0.463 
C06 0.327 0.159 0.345 0.159 0.335 0.329 
C07 0.346 0.265 0.092 0.542 0.469 0.518 
C11 0.089 0.146 0.124 0.166 0.489 0.226 
C22 0.113 0.454 0.327 0.385 0.249 0.529 
C26 0.364 0.476 0.422 0.404 0.378 0.521 
Average Osteonal Radius (µm) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 63.90 61.07 85.90 100.51 49.24 95.45 
C03 69.32 65.99 52.73 60.40 45.66 55.15 
C06 71.59 79.90 141.62 37.52 48.08 52.33 
C07 65.01 60.20 26.84 76.92 61.72 63.71 
C11 61.76 27.96 34.26 50.32 60.26 40.83 
C22 64.43 63.68 63.45 60.74 50.11 68.27 
C26 54.89 60.98 62.41 69.10 55.90 67.78 
Average CLI (Tissue) (mm/mm2) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 54.75 49.67 55.75 52.33 36.00 40.50 
C03 53.33 56.25 25.25 10.25 54.75 52.75 
C06 18.75 19.00 32.50 18.00 31.00 33.75 
C07 29.75 17.00 10.75 45.50 47.00 41.50 
C11 6.75 10.00 12.50 12.00 48.50 18.67 
C22 10.33 40.00 35.00 36.75 22.50 36.50 
C26 30.75 43.75 41.75 35.67 35.50 44.50 
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Average CLI (Material) (mm/mm2) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C01 55.54 52.59 59.96 53.96 38.69 41.83 
C03 55.44 59.13 26.56 10.50 57.87 56.11 
C06 19.35 19.98 33.40 18.79 33.27 33.99 
C07 30.19 18.00 11.79 47.25 49.10 42.41 
C11 7.29 10.53 13.27 12.64 49.52 19.02 
C22 10.56 40.98 35.32 37.77 23.09 38.82 
C26 32.35 44.05 42.98 38.46 36.59 45.21 
12 Month Autumn Control 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 0.972 0.958 0.986 0.965 0.951 0.972 
C46 0.986 0.993 0.979 0.951 0.986 0.986 
C47 0.951 0.958 0.965 0.986 0.951 0.951 
C50 0.986 0.979 0.958 0.965 0.965 0.979 
C54 0.986 0.981 0.972 1.000 0.986 0.986 
C55 0.944 0.979 0.979 0.931 0.972 0.979 
            
Average Percent Remodeled (Tissue) (Remodeled Tissue/Total Area) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 0.264 0.507 0.500 0.278 0.528 0.465 
C46 0.188 0.444 0.201 0.285 0.458 0.208 
C47 0.222 0.389 0.264 0.250 0.424 0.326 
C50 0.111 0.368 0.313 0.306 0.458 0.271 
C54 0.306 0.333 0.236 0.493 0.389 0.250 
C55 0.264 0.354 0.319 0.069 0.326 0.500 
            
Average Percent Remodeled (Material) (Remodeled Tissue/Bone Area) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 0.271 0.529 0.505 0.288 0.555 0.479 
C46 0.190 0.448 0.206 0.299 0.465 0.211 
C47 0.233 0.406 0.274 0.254 0.446 0.344 
C50 0.113 0.375 0.326 0.317 0.474 0.276 
C54 0.310 0.341 0.242 0.493 0.395 0.254 
C55 0.279 0.362 0.325 0.075 0.335 0.511 
            
Average Osteonal Radius (µm) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 55.00 58.80 64.28 52.59 66.48 57.53 
C46 57.37 63.44 55.08 59.94 54.31 53.03 
C47 55.48 52.13 54.36 48.70 53.22 58.03 
C50 56.86 52.58 44.09 57.86 60.12 52.79 
C54 49.52 50.55 60.66 57.99 50.35 57.53 
C55 62.09 49.59 58.82 43.10 43.68 56.82 
            
Average CLI (Tissue) (mm/mm2) 
Sector 
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Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 29.25 60.50 42.25 36.25 57.50 44.25 
C46 20.75 48.25 24.75 29.25 58.75 26.50 
C47 22.75 52.50 28.75 24.50 55.50 28.25 
C50 13.25 53.00 35.25 31.00 42.25 26.50 
C54 38.00 50.33 28.75 48.25 48.25 27.00 
C55 23.00 50.50 33.50 12.00 45.75 49.25 
            
Average CLI (Material) (mm/mm2) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C44 30.09 63.30 42.75 37.59 60.47 45.54 
C46 21.05 48.60 25.32 30.81 59.67 26.90 
C47 23.83 54.55 29.78 24.83 58.52 29.76 
C50 13.47 54.10 36.76 32.14 43.81 27.02 
C54 38.49 51.37 29.50 48.25 48.96 27.47 
C55 24.38 51.59 34.09 12.93 46.98 50.31 
            
12 Month Winter Control 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 0.938 0.847 0.979 0.965 0.847 0.938 
C75 0.965 0.993 0.958 0.938 0.958 0.944 
C77 0.944 0.979 0.938 0.951 0.954 0.979 
C80 0.944 0.979 0.972 0.000 0.972 0.972 
C82 0.944 0.910 0.951 0.944 0.868 0.944 
C83 0.958 0.965 0.958 0.000 0.986 0.979 
C84 0.965 0.958 0.965 0.931 0.965 0.958 
Average Percent Remodeled (Tissue) (Remodeled Tissue/Total Area) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 0.042 0.229 0.069 0.132 0.299 0.167 
C75 0.083 0.431 0.118 0.188 0.563 0.167 
C77 0.326 0.438 0.007 0.486 0.500 0.708 
C80 0.264 0.417 0.188 0.000 0.465 0.118 
C82 0.063 0.299 0.083 0.611 0.326 0.042 
C83 0.132 0.417 0.028 0.000 0.368 0.431 
C84 0.014 0.243 0.035 0.021 0.417 0.188 
Average Percent Remodeled (Material) (Remodeled Tissue/Bone Area) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 0.044 0.272 0.072 0.139 0.352 0.179 
C75 0.086 0.434 0.125 0.199 0.587 0.174 
C77 0.345 0.446 0.008 0.512 0.521 0.723 
C80 0.279 0.426 0.196 0.000 0.479 0.121 
C82 0.068 0.333 0.089 0.648 0.374 0.044 
C83 0.138 0.433 0.028 0.000 0.373 0.440 
C84 0.015 0.253 0.036 0.022 0.432 0.194 
 
 
Average Osteonal Radius (µm) 
Sector 
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Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 37.97 52.97 44.50 53.49 53.17 50.67 
C75 54.43 51.13 59.53 44.76 57.65 49.62 
C77 60.57 52.98 37.38 53.72 50.32 68.93 
C80 61.66 51.18 53.06 0.00 59.06 48.95 
C82 38.68 54.34 53.89 68.50 57.58 44.14 
C83 67.23 50.71 50.59 0.00 50.95 51.99 
C84 35.24 57.27 55.01 45.26 53.77 56.86 
Average CLI (Tissue) (mm/mm2) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 7.25 30.25 7.00 16.25 38.75 20.00 
C75 8.75 50.75 13.50 28.50 55.25 22.75 
C77 29.75 51.00 0.50 54.75 57.67 50.00 
C80 26.75 51.00 22.50 0.00 52.50 14.75 
C82 9.50 36.00 7.75 47.50 37.00 8.50 
C83 10.50 49.75 3.50 0.00 48.50 51.75 
C84 3.50 26.00 4.25 2.50 41.75 21.75 
Average CLI (Material) (mm/mm2) 
Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C59 7.72 35.98 7.27 17.00 45.66 21.43 
C75 9.04 51.14 14.30 30.34 57.71 23.93 
C77 31.50 51.97 0.56 57.66 60.61 51.05 
C80 28.41 52.13 23.38 0.00 54.08 15.19 
C82 10.32 39.59 8.19 50.48 42.45 9.14 
C83 10.95 51.55 3.67 0.00 49.11 52.89 
C84 3.65 27.16 4.37 2.68 43.29 22.51 
12 Month Spring Control 
Average BV/TV 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 0.938 0.958 0.972 0.965 0.938 0.958 
C96 0.986 0.958 0.951 0.944 0.958 0.924 
C97 0.958 1.000 0.951 0.924 0.944 0.965 
C99 0.972 0.986 0.979 0.938 0.931 0.951 
C103 0.993 0.944 0.972 0.965 0.931 0.979 
C108 0.965 0.931 0.972 0.958 0.965 0.951 
C109 0.951 0.979 0.951 0.951 0.972 0.951 
Average Percent Remodeled (Tissue) (Remodeled Tissue/Total Area) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 0.174 0.125 0.306 0.549 0.590 0.535 
C96 0.160 0.250 0.090 0.215 0.521 0.410 
C97 0.410 0.389 0.118 0.403 0.549 0.125 
C99 0.035 0.396 0.389 0.292 0.125 0.076 
C103 0.083 0.313 0.000 0.444 0.479 0.389 
C108 0.090 0.188 0.007 0.153 0.542 0.188 
C109 0.118 0.382 0.444 0.444 0.083 0.528 
Average Percent Remodeled (Material) (Remodeled Tissue/Bone Area) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 0.184 0.129 0.316 0.569 0.627 0.557 
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C96 0.163 0.261 0.095 0.228 0.544 0.444 
C97 0.426 0.389 0.125 0.434 0.581 0.129 
C99 0.036 0.399 0.396 0.313 0.132 0.080 
C103 0.084 0.329 0.000 0.459 0.514 0.398 
C108 0.093 0.203 0.007 0.158 0.562 0.199 
C109 0.124 0.390 0.469 0.465 0.087 0.554 
Average Osteonal Radius (µm) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 48.97 43.73 58.21 80.83 67.27 61.33 
C96 50.45 55.82 38.74 43.50 60.55 55.43 
C97 62.01 52.53 51.41 64.80 64.41 53.87 
C99 33.40 55.53 57.72 56.27 74.76 32.80 
C103 61.16 51.76 0.00 58.82 53.10 55.68 
C108 53.94 69.94 26.43 56.91 66.49 59.42 
C109 44.13 57.40 66.36 63.98 59.86 62.72 
Average CLI (Tissue) (mm/mm2) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 28.50 14.50 36.50 39.50 47.75 49.00 
C96 19.75 28.00 11.75 32.75 43.75 49.00 
C97 33.75 41.00 17.25 29.50 44.00 16.50 
C99 6.75 37.50 43.75 35.25 9.00 14.25 
C103 7.25 35.75 0.00 43.25 45.75 40.50 
C108 9.75 15.25 2.00 18.25 43.50 24.25 
C109 14.25 39.50 46.00 39.50 6.50 52.00 
Average CLI (Material) (mm/mm2) 
  Sector 
Sheep Craniomedial Cranial Craniolateral Caudomedial Caudal Caudolateral 
C91 30.23 14.95 37.65 40.95 51.53 51.17 
C96 20.14 29.22 12.38 34.78 45.60 53.18 
C97 35.06 41.00 18.32 31.95 46.51 17.10 
C99 7.00 37.84 44.59 37.88 9.53 15.00 
C103 7.30 37.90 0.00 44.71 49.19 41.41 
C108 10.07 16.48 2.04 19.07 45.06 25.47 
C109 14.97 40.36 48.38 41.62 6.71 54.64 
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Appendix B 12 Month Control Densitometry Data 
Key Sheep Specimen Season Sector Mean Pixel Intensity ETA (mm) 
10 C44 C4414 Autumn Craniomedial 172.7765 0.09501686 
10 C44 C4412 Autumn Cranial 198.5427 0.100925894 
10 C44 C4407 Autumn Craniolateral 176.8247 0.095976794 
10 C44 C4418 Autumn Caudomedial 132.9139 0.084792749 
10 C44 C4411 Autumn Caudal 168.4556 0.09397811 
10 C44 C4403 Autumn Caudolateral 77.5224 0.067101784 
10 C46 C4611 Autumn Craniomedial 200.3506 0.10132375 
10 C46 C4608 Autumn Cranial 197.8032 0.100762566 
10 C46 C4605 Autumn Craniolateral 251.2486 0.111784562 
10 C46 C4613 Autumn Caudomedial 224.8937 0.106535329 
10 C46 C4607 Autumn Caudal 217.7813 0.105059675 
10 C46 C4603 Autumn Caudolateral 212.5517 0.103957172 
11 C47 C4712 Autumn Craniomedial 124.2711 0.100330882 
11 C47 C4711 Autumn Cranial 121.618 0.099388679 
11 C47 C4706 Autumn Craniolateral 65.3278 0.075741246 
11 C47 C4715 Autumn Caudomedial 97.5209 0.090241822 
11 C47 C4709 Autumn Caudal 116.1901 0.097424342 
11 C47 C4703 Autumn Caudolateral 71.5131 0.078796984 
11 C50 C5012 Autumn Craniomedial 184.4855 0.11924973 
11 C50 C5010 Autumn Cranial 190.7018 0.120990162 
11 C50 C5005 Autumn Craniolateral 170.6471 0.11525289 
25 C50 C5015 Autumn Caudomedial 187.6702 0.120145433 
11 C50 C5007 Autumn Caudal 60.0003 0.111860173 
11 C50 C5004 Autumn Caudolateral 180.607 0.118147062 
12 C54 C5420 Autumn Craniomedial 58.7373 0.077361957 
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12 C54 C5418 Autumn Cranial 175.7131 0.119257354 
12 C54 C5412 Autumn Craniolateral 136.6325 0.107978106 
12 C54 C5423 Autumn Caudomedial 98.3766 0.094839619 
12 C54 C5415 Autumn Caudal 121.1593 0.102972169 
12 C54 C5409 Autumn Caudolateral 91.5002 0.092163825 
13 C55 C5512 Autumn Craniomedial 81.3381 0.09434105 
13 C55 C5510 Autumn Cranial 127.7924 0.112495111 
13 C55 C5505 Autumn Craniolateral 140.226 0.116638374 
13 C55 C5515 Autumn Caudomedial 129.2474 0.112992328 
13 C55 C5507 Autumn Caudal 45.3482 0.075138064 
13 C55 C5503 Autumn Caudolateral 71.9124 0.089921568 
2 C75 C7405 Winter Craniomedial 17.3362 0.084593797 
2 C75 C7501 Winter Cranial 22.7143 0.092846349 
2 C75 C7517 Winter Craniolateral 19.2933 0.087769124 
2 C75 C7506 Winter Caudomedial 28.6612 0.100590809 
2 C75 C7511 Winter Caudal 15.7269 0.081801669 
2 C75 C7514 Winter Caudolateral 36.5457 0.109375037 
2 C77 C7703 Winter Craniomedial 43.0213 0.115697926 
2 C77 C7701 Winter Cranial 29.7938 0.101942875 
2 C77 C7719 Winter Craniolateral 50.389 0.12217342 
2 C77 C7706 Winter Caudomedial 28.0252 0.09981616 
2 C77 C7710 Winter Caudal 26.3054 0.097661999 
2 C77 C7715 Winter Caudolateral 19.1599 0.087559579 
3 C80 C8003 Winter Craniomedial 5.9776 0.089341979 
3 C80 C8001 Winter Cranial 15.3021 0.110292157 
3 C80 C8017 Winter Craniolateral 13.5217 0.10727666 
3 C80 C8006 Winter Caudomedial 4.2049 0.082569051 
3 C80 C8009 Winter Caudal 8.1626 0.095802902 
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3 C80 C8013 Winter Caudolateral 9.3176 0.098686963 
3 C83 C8302 Winter Craniomedial 10.8348 0.102080567 
3 C83 C8314 Winter Cranial 16.8236 0.112660315 
3 C83 C8311 Winter Craniolateral 16.7434 0.112539728 
3 C83 C8305 Winter Caudomedial 3.9852 0.081581968 
3 C83 C8308 Winter Caudal 12.4731 0.105353381 
3 C83 C8310 Winter Caudolateral 7.9961 0.095361434 
5 C82 C8202 Winter Craniomedial 11.494 0.077730519 
5 C82 C8218 Winter Cranial 13.35 0.081898429 
5 C82 C8215 Winter Craniolateral 32.9326 0.112229453 
5 C82 C8205 Winter Caudomedial 12.4761 0.079986403 
5 C82 C8209 Winter Caudal 14.8269 0.084952471 
5 C82 C8213 Winter Caudolateral 18.0087 0.090915288 
5 C84 C8402 Winter Craniomedial 14.0008 0.083269991 
5 C84 C8423 Winter Cranial 32.3698 0.111556466 
5 C84 C8420 Winter Craniolateral 30.8389 0.109686418 
5 C84 C8406 Winter Caudomedial 41.4777 0.121637006 
5 C84 C8411 Winter Caudal 24.1241 0.100679302 
5 C84 C8417 Winter Caudolateral 24.0128 0.10051698 
12 C59 C5904 Winter Craniomedial 147.7237 0.111128865 
12 C59 C5901 Winter Cranial 77.9116 0.086317913 
12 C59 C5912 Winter Craniolateral 170.0527 0.117481442 
12 C59 C5905 Winter Caudomedial 147.7092 0.111124558 
12 C59 C5908 Winter Caudal 97.5877 0.094345391 
12 C59 C5910 Winter Caudolateral 118.7244 0.101940219 
14 C103 C10312 Spring Craniomedial 65.8778 0.086881496 
14 C103 C10308 Spring Cranial 67.639 0.087689488 
14 C103 C10306 Spring Craniolateral 99.1794 0.100292811 
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14 C103 C10313 Spring Caudomedial 94.2229 0.09850489 
14 C103 C10301 Spring Caudal 71.9 0.08958939 
14 C103 C10303 Spring Caudolateral 127.2903 0.109469812 
18 C91 C9120 Spring Craniomedial 149.1565 0.140153638 
18 C91 C9109 Spring Cranial 60.5506 0.105727551 
18 C91 C9112 Spring Craniolateral 46.3238 0.097234558 
18 C91 C9118 Spring Caudomedial 128.9875 0.133929684 
18 C91 C9101 Spring Caudal 44.139 0.095776813 
18 C91 C9106 Spring Caudolateral 16.7868 0.070792311 
19 C96 C9615 Spring Craniomedial 80.8929 0.101466725 
19 C96 C9607 Spring Cranial 97.1444 0.107639788 
19 C96 C9606 Spring Craniolateral 100.0217 0.108658143 
19 C96 C9614 Spring Caudomedial 83.479 0.102502058 
19 C96 C9601 Spring Caudal 40.804 0.081366197 
19 C96 C9604 Spring Caudolateral 57.8857 0.091082938 
20 C99 C9914 Spring Craniomedial 45.2735 0.091092131 
20 C99 C9909 Spring Cranial 33.5372 0.082924239 
20 C99 C9906 Spring Craniolateral 111.1485 0.120670087 
20 C99 C9917 Spring Caudomedial 102.7885 0.11775187 
20 C99 C9911 Spring Caudal 66.0649 0.102533363 
25 C99 C9904 Spring Caudolateral 54.9245 0.108222154 
22 C108 C10819 Spring Craniomedial 63.5892 0.114333834 
22 C108 C10808 Spring Cranial 126.1518 0.127219225 
22 C108 C10806 Spring Craniolateral 80.0818 0.118518714 
22 C108 C10814 Spring Caudomedial 56.2488 0.112168432 
22 C108 C10811 Spring Caudal 47.9457 0.109410187 
22 C108 C10804 Spring Caudolateral 15.5686 0.091813577 
23 C109 C10914 Spring Craniomedial 88.2094 0.106942229 
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23 C109 C10918 Spring Cranial 96.0997 0.10981393 
23 C109 C10906 Spring Craniolateral 53.2935 0.091508551 
23 C109 C10910 Spring Caudomedial 79.2492 0.103457164 
23 C109 C10901 Spring Caudal 51.3666 0.090472148 
23 C109 C10904 Spring Caudolateral 94.6498 0.109298783 
25 C97 C9712 Spring Craniomedial 112.6496 0.12528764 
25 C97 C9706 Spring Cranial 78.2456 0.116317702 
25 C97 C9707 Spring Craniolateral 81.1494 0.117184921 
25 C97 C9714 Spring Caudomedial 71.2028 0.114102658 
25 C97 C9702 Spring Caudal 62.6332 0.111158623 
25 C97 C9705 Spring Caudolateral 56.9746 0.109033611 
1/3 C01 C0121 Summer Craniomedial 22.5089 0.035315395 
1/3 C01 C0114 Summer Cranial 121.8515 0.084315695 
1/3 C01 C0111 Summer Craniolateral 110.6426 0.08022577 
1/3 C01 C0117 Summer Caudomedial 56.1824 0.056579122 
1/3 C01 C0103 Summer Caudal 64.0588 0.060536314 
1/3 C01 C0107 Summer Caudolateral 91.0314 0.072552736 
1/3 C03 C0303 Summer Craniomedial 99.8502 0.076093259 
1/3 C03 C0302 Summer Cranial 170.3762 0.100212429 
1/3 C03 C0309 Summer Craniolateral 131.8323 0.08780642 
1/3 C03 C0306 Summer Caudomedial 50.7176 0.053673069 
1/3 C03 C0315 Summer Caudal 78.2818 0.067125481 
6/7 C03 C0312 Summer Caudolateral 87.8231 0.071223695 
6/7 C06 C0603 Summer Craniomedial 142.5787 0.125819464 
6/7 C06 C0608 Summer Cranial 143.5876 0.126188924 
6/7 C06 C0610 Summer Craniolateral 157.6414 0.131185169 
6/7 C06 C0606 Summer Caudomedial 130.6262 0.121320998 
6/7 C06 C0615 Summer Caudal 62.6464 0.089377626 
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6/7 C06 C0613 Summer Caudolateral 119.2924 0.116827421 
6/7 C07 C0715 Summer Craniomedial 63.5545 0.089914112 
6/7 C07 C0717 Summer Cranial 56.085 0.085358779 
6/7 C07 C0703 Summer Craniolateral 105.1457 0.110853189 
6/7 C07 C0711 Summer Caudomedial 75.8497 0.096775881 
6/7 C07 C0707 Summer Caudal 81.918 0.099923265 
6/7 C07 C0705 Summer Caudolateral 57.6736 0.086355979 
S11 C11 C1108 Summer Craniomedial 151.2129 0.09411656 
S11 C11 C1120 Summer Cranial 108.0243 0.080612703 
S11 C11 C1117 Summer Craniolateral 136.6505 0.089828633 
S11 C11 C1107 Summer Caudomedial 161.1128 0.096905514 
S11 C11 C1111 Summer Caudal 116.6815 0.083525856 
S11 C11 C1114 Summer Caudolateral 84.4119 0.071957624 
22/2
6 C22 C2207 Summer Craniomedial 128.4149 0.086523167 
22/2
6 C22 C2215 Summer Cranial 145.6573 0.092276679 
22/2
6 C22 C2217 Summer Craniolateral 122.7761 0.084560466 
22/2
6 C22 C2211 Summer Caudomedial 159.8207 0.096757602 
22/2
6 C22 C2222 Summer Caudal 170.8631 0.100117844 
22/2
6 C22 C2219 Summer Caudolateral 59.1273 0.05821277 
22/2
6 C26 C2612 Summer Craniomedial 103.6656 0.077556915 
22/2
6 C26 C2601 Summer Cranial 55.8375 0.056534569 
22/2
6 C26 C2603 Summer Craniolateral 94.8877 0.074128636 
22/2
6 C26 C2614 Summer Caudomedial 46.2053 0.051320817 
22/2
6 C26 C2609 Summer Caudal 57.0123 0.057139276 
22/2
6 C26 C2606 Summer Caudolateral 81.5244 0.068596289 
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Appendix C Densitometry Aluminum Step Wedge Keys 
Autumn 
Step #  ETA [0.025mm/Step] 
KEYS Mean Pixel Intensity 
10  11  12  13  25 
1  0.025  7.1978  4.909  3.1097  2.6303  0.0071 
2  0.050  41.5899  24.1583  18.593  14.8564  2.0826 
3  0.075  118.4469  72.9365  64.1272  49.6613  11.2983 
4  0.100  220.5816  135.6588 134.1584  104.416  44.0515 
5  0.125  253.9084  222.2152 201.9778  176.6639  125.8284
6  0.150  253.2734 247.3346  228.566  211.8184
7  0.175              253.998 
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Winter 
Step #  ETA [0.025mm/Step] 
KEYS Mean Pixel Intensity 
2  3  5  12 
1  0.025  1.0002  0  0.9995  3.0798 
2  0.050  2.1526  0.263  1.848  19.1424 
3  0.075  7.2075  1.9993  5.5781  64.4665 
4  0.100  19.7897  7.9691  14.6054  134.7307 
5  0.125  51.9307  26.7677  37.5965  201.8678 
6  0.150  123.1663 75.1163  95.716  247.6778 
7  0.175  198.1668 164.7528  181.9852    
8  0.200  248.8933 229.3546  247.9746    
9  0.225  253.9911    
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Spring 
Step 
# 
ETA 
[0.025m
m/Step] 
KEYS Mean Pixel Intensity 
14  18  19  20  22  23  25 
1  0.025  1.942  0.9989  1.1982  1.0009  0.0006  1.0041  0.0187 
2  0.050  11.0109  2.5484  7.2852  4.3628  1.8553  5.4219  2.1678 
3  0.075  47.4988  15.4494  29.1147  19.4118  12.2434  23.5392  12.2799
4  0.100  131.6477  53.1272  83.2881  61.9213  47.0203  79.2201  47.7626 
5  0.125  191.9769  160.116  182.3101  159.8455  129.1476  182.3045  131.0924 
6  0.150  248.4841  232.7273  252.8799  237.7506  205.5176  250.909  210.9074 
7  0.175  253.9877  253.7837  253.9978 
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Summer 
Step #  ETA [0.025mm/Step]
KEYS Mean Pixel Intensity 
01/03  06/07  S11  22/26 
1  0.025  11.5987  3.1845  8.6335  12.5159 
2  0.050  40.484  11.4204  34.7321  34.681 
3  0.075  108.1602 41.4837  99.4100  101.5184 
4  0.100  180.0585 107.9134  194.4416  195.2673 
5  0.125  239.7927 166.5719  250.5824  252.0189 
6  0.150  216.8735 
7  0.175  250.4502    
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